HLA-DPB1 and neoplasm: Fewer tumor infiltrating CD8+ T lymphocytes were reported to be associated with lower HLA-DPA1 and HLA-DPB1 expression in several pathologies [58], supporting the hypothesis that the loss of tumor immunosurveillance can have a devastating effect on tumor antigen presentation, loss of mature CTL, and patient outcome.